Laboratory Test Detail

Last Updated: April 26, 2024 @ 9:13 am

2296

Free T3

Specimen:Collect:
  • One SST

Also Acceptable:
  • One Green Top (Li Heparin)
  • One Lavender (EDTA)
  • One Pink Top (EDTA)
  • One Red Top
Submit:
  • 1 mL (Min:0.5 mL) Serum . Submit Refrigerated. Submit in a Standard Transport Tube.

Also Acceptable:
  • 1 mL (Min:0.5 mL) Plasma . Submit Refrigerated. Submit in a Standard Transport Tube.
Special Handling:
  • Allow specimen to clot completely at room temperature
  • Avoid Repeated Freeze/Thaw Cycles
  • For patients receiving therapy with high biotin doses (>5 mg/day), no laboratory test specimen should be collected until at least 8 hours after the last biotin administration.
Stability:Ambient: 5 Day(s); Refrigerated: 7 Day(s); Frozen: 1 Month(s); Incubated: Unacceptable
Methodology:
  • Electrochemiluminescence Immunoassay (ECLIA)
Performed:Mon-Fri
Reported:1-3 Day(s)
CPT Codes:
  • 84481
Interpretive Data:
Male Reference Ranges
  • 0 - 3 week(s) : 2.0-5.2 pg/ml
  • 3 week(s) - 2 year(s) : 1.5-6.4 pg/ml
  • 2 - 7 year(s) : 2.0-6.0 pg/ml
  • 7 - 12 year(s) : 2.7-5.2 pg/ml
  • 12 - 19 year(s) : 2.3-5.0 pg/ml
  • 19 - 150 year(s) : 2.5-4.3 pg/ml

Female Reference Ranges
  • 0 - 3 week(s) : 2.0-5.2 pg/ml
  • 3 week(s) - 2 year(s) : 1.5-6.4 pg/ml
  • 2 - 7 year(s) : 2.0-6.0 pg/ml
  • 7 - 12 year(s) : 2.7-5.2 pg/ml
  • 12 - 19 year(s) : 2.3-5.0 pg/ml
  • 19 - 150 year(s) : 2.5-4.3 pg/ml


Biotin in specimens taken from patients on high-dose biotin therapy or supplements may intefere with this test and cause inaccurate test results. It is recommended that for patients receiving therapy with high biotin doses (> 5 mg/day), no laboratory test specimen should be collected until at least 8 hours after the last biotin administration.
Components:
  • 2296 - FREE T3
Print Friendly, PDF & Email

Disclaimer:
It is preferable to locate tests on the website and not rely on printed test information, which may soon be out of date.
Updated test information can only be guaranteed by using this website.